WHO Prequalifies First G6PD Diagnostic Test To Enhance P. Vivax Malaria Treatment

…Milestone Aims to Improve Safe, Equitable Malaria Care Globally The World Health Organisation (WHO) has achieved a significant milestone in the global fight against malaria by prequalifying the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency. This breakthrough promises to revolutionise the treatment of Plasmodium vivax (P. vivax) malaria by facilitating safer…